← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Io Therapeutics, Inc.
Santa Ana, CA
$2,079,395
Total funding
2
Grants
Funding over time
peak $1M · FY2014–17$1M$750K$500K$250K$0
'14
'15
'16
'17
Funding mix
By agency
NIH$2,079,395 · 2
By mechanism
R44$1,854,395 · 1
R43$225,000 · 1
Investigators at Io Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of the RXR agonist IRX4204 to treat Multiple Sclerosis and other Immune related Diseases$1,000,000
R44 · FY2017 · AI
Development of the RXR agonist IRX4204 to treat Multiple Sclerosis and other Immune related Diseases$854,395
R44 · FY2016 · AI
Development of the RXR agonist IRX4204 to treat Multiple Sclerosis and other Immu$225,000
R43 · FY2014 · AI